Vaccination of Immunocompromised Cats

Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie

doi:10.3390/v14050923

Vaccination of Immunocompromised Cats

Katrin Hartmann, Karin Möstl, Albert Lloret, Etienne Thiry, Diane D Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Regina Hofmann-Lehmann, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Séverine Tasker, Uwe Truyen, Margaret J Hosie

Research output: Contribution to journal › Review article › peer-review

Abstract

Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.

Original language	English
Article number	923
Pages (from-to)	1-24
Journal	Viruses
Volume	14
Issue number	5
DOIs	https://doi.org/10.3390/v14050923
Publication status	Published - May 2022

Bibliographical note

Funding Information:
Funding: ABCD Europe gratefully acknowledges the support of Boehringer Ingelheim (the founding sponsor of the ABCD), Virbac, and IDEXX.

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

feline
immunocompromise
immunosuppression
immunodeficiency
vaccine
efficacy
safety
duration of immunity
DOI

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/v14050923Licence: CC BY

viruses-14-00923-v2Final published version, 428 KBLicence: CC BY

Cite this

@article{a1a7c686932d4b4782ee9f99b47217d3,

title = "Vaccination of Immunocompromised Cats",

abstract = "Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.",

keywords = "feline, immunocompromise, immunosuppression, immunodeficiency, vaccine, efficacy, safety, duration of immunity, DOI",

author = "Katrin Hartmann and Karin M{\"o}stl and Albert Lloret and Etienne Thiry and Addie, {Diane D} and S{\'a}ndor Bel{\'a}k and Corine Boucraut-Baralon and Herman Egberink and Tadeusz Frymus and Regina Hofmann-Lehmann and Hans Lutz and Fulvio Marsilio and Pennisi, {Maria Grazia} and S{\'e}verine Tasker and Uwe Truyen and Hosie, {Margaret J}",

note = "Funding Information: Funding: ABCD Europe gratefully acknowledges the support of Boehringer Ingelheim (the founding sponsor of the ABCD), Virbac, and IDEXX. Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = may,

doi = "10.3390/v14050923",

language = "English",

volume = "14",

pages = "1--24",

journal = "Viruses",

issn = "1999-4915",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "5",

}

TY - JOUR

T1 - Vaccination of Immunocompromised Cats

AU - Hartmann, Katrin

AU - Möstl, Karin

AU - Lloret, Albert

AU - Thiry, Etienne

AU - Addie, Diane D

AU - Belák, Sándor

AU - Boucraut-Baralon, Corine

AU - Egberink, Herman

AU - Frymus, Tadeusz

AU - Hofmann-Lehmann, Regina

AU - Lutz, Hans

AU - Marsilio, Fulvio

AU - Pennisi, Maria Grazia

AU - Tasker, Séverine

AU - Truyen, Uwe

AU - Hosie, Margaret J

N1 - Funding Information: Funding: ABCD Europe gratefully acknowledges the support of Boehringer Ingelheim (the founding sponsor of the ABCD), Virbac, and IDEXX. Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2022/5

Y1 - 2022/5

N2 - Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.

AB - Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.

KW - feline

KW - immunocompromise

KW - immunosuppression

KW - immunodeficiency

KW - vaccine

KW - efficacy

KW - safety

KW - duration of immunity

KW - DOI

UR - http://www.scopus.com/inward/record.url?scp=85129834912&partnerID=8YFLogxK

U2 - 10.3390/v14050923

DO - 10.3390/v14050923

M3 - Review article

C2 - 35632665

SN - 1999-4915

VL - 14

SP - 1

EP - 24

JO - Viruses

JF - Viruses

IS - 5

M1 - 923

ER -

Vaccination of Immunocompromised Cats

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this